Autopsy report · NCT05462561

Vascularized Composite Bladder Allograft Transplantation

“pending UNOS approval”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months before it started.
• Suspended: paused, and may or may not restart.
• 5 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

University of Southern California

Sponsor type

University, hospital or other

Conditions

Neurogenic Bladder; Bladder Dysfunction; Immunosuppression

Interventions

Quality-of-Life Assessment; Robotic Vascularized Composite Bladder Allograft Transplantation

Participants

5 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCs
  “no approval” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.